Outcome of culture-negative pyogenic vertebral osteomyelitis: Comparison with microbiologically confirmed pyogenic vertebral osteomyelitis

Jungok Kim,Yeon-Sook Kim,Kyong Ran Peck,Eun-Sang Kim,Sun Young Cho,Young Eun Ha,Cheol-In Kang,Doo Ryeon Chung,Jae-Hoon Song
DOI: https://doi.org/10.1016/j.semarthrit.2014.04.008
IF: 5.431
2014-01-01
Seminars in Arthritis and Rheumatism
Abstract:Objectives: Although pyogenic vertebral osteomyelitis (PVC) with no identified microorganism is treated empirically, the clinical outcome is not well understood. Methods: We conducted a retrospective review of patients with PVC) at a tertiary-care hospital from 2000 through 2012. The study compared clinical features and outcomes of microbiologically confirmed (M-PVC) with clinically diagnosed PVC) (C-PVC). Results: Of 151 patients with PVC, 75 (49.7%) had M-PVO. Compared to patients with M-PVO, patients with C-PVC had fewer underlying medical conditions. In addition, they presented less frequently with fever, high acute-phase reactants levels, and paraspinal abscess. The rate of treatment failure tended to be lower in the C-PVC group [9.2% (7/76) vs. 17.3% (13/75); p = 0.157]. The overall relapse rate was 6.6% and did not differ significantly between groups; notably this rate was higher in patients who received antibiotics for <= 6 weeks [18.8% (3/16)] and <= 8 weeks [12.1% (4/33)]. The independent risk factors for treatment failure were higher CRP levels [odds ratio (OR) = 1.087; 95% confidence interval (CI): 1.025-1.153 p = 0.005] and fever >= 37.8 degrees C (OR = 8.556; 95% CI: 2.273-32.207; p = 0.002). Conclusions: Patients with C-PVC had less systemic inflammatory response and a more favorable outcome compared to M-PVO. Prolonged antibiotic therapy, for at least 8 weeks, might be required for C-PVC, as well as for M-PVC until better outcomes are assured. (C) 2014 Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?